Archive 2002
Whether biocompatible membranes and high flux have a favourable influence on clinical outcomes in ARF is an open and debated issue. Prof Lameire offers a well pondered view of this problem.
Lupus nephritis is a continuous challange for renal physicians. Prof Berden illustrates recent advancement in the understanding and treatment of this disease.
Gene chips have revolutionised molecular biology and genetics. Dr Martin illustrates present and future applications of these technical advancements.
Dr Furness reminds us that renal biopsy is accurate but not infallible.
Guidelines development demands a rigorous methodology. Prof Vanholder illustrates how hemodialysis EBPG were constructed.
Guidelines are fundamental to spread evidence based medical practice but they should not be viewed as a faultless instrument. Prof Wanner discusses how the process of guidelines building can be furthered.
Osteopenia is a growing problem in patients with chronic renal failure. Dr. Drüeke illustrates new therapeutic strategies.
Renal Registries are an invaluble source of information for nephrologists and health planners alike. Dr. Løkkegaard identifies some major problems which may be encountered in the construction of large scale renal registries.
After Dr. van der Woude presentation on the diagnosis of vasculitis, Dr. Pusey focuses the attention on the treatment of rapidly progressive glomerulonephritis.
Registries are the centre stage of clinical research in Nephrology. Dr. Jager presents the projects and the opportunities offered by the new ERA registry.
Prof. Krediet gives a clear and exhaustive presentation about peritoneal membrane function with respect to fluid transport